title: Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment.
authors.forename: G P
authors.initials: GP
authors.lastname: Wormser
authors.forename: E D
authors.initials: ED
authors.lastname: Shapiro
authors.forename: J J
authors.initials: JJ
authors.lastname: Halperin
authors.forename: R B
authors.initials: RB
authors.lastname: Porwancher
authors.forename: S
authors.initials: S
authors.lastname: O'Connell
authors.forename: R B
authors.initials: RB
authors.lastname: Nadelman
authors.forename: F
authors.initials: F
authors.lastname: Strle
authors.forename: J D
authors.initials: JD
authors.lastname: Radolf
authors.forename: J W R
authors.initials: JW
authors.lastname: Hovius
authors.forename: P J
authors.initials: PJ
authors.lastname: Baker
authors.forename: V
authors.initials: V
authors.lastname: Fingerle
authors.forename: R
authors.initials: R
authors.lastname: Dattwyler
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D015986:Confounding Factors, Epidemiologic; D004311:Double-Blind Method; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000592:standards
chemical_list: D000900:Anti-Bacterial Agents; D000658:Amoxicillin